205470.KQ
Humasis Co. Ltd.
KOE · Healthcare · Medical - Equipment & Services · KR
KRW 2,835.00
−3.57%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 31.7B | 30.1B | 25.4B | 13.8B | 471.3B |
| Cost of Revenue | 28.3B | 27.9B | 24.3B | 50.8B | 216.0B |
| Gross Profit | 3.4B | 2.2B | 1.1B | (36.9B) | 255.3B |
| Operating Expenses | |||||
| R&D Expense | 522.6M | 406.9M | 1.5B | 4.1B | 5.2B |
| SG&A Expense | 5.6B | 4.3B | 4.6B | 5.0B | 35.2B |
| General & Admin Expense | 1.2B | 1.2B | 1.7B | 531.9M | 1.1B |
| Selling & Marketing Expense | 4.3B | 3.1B | 2.9B | 4.5B | 21.2B |
| Other Expenses | 11.5B | 11.6B | 5.6B | 6.3B | 94.4M |
| Total Operating Expenses | 17.6B | 16.3B | 11.7B | 15.4B | 40.6B |
| Cost and Expenses | 45.9B | 44.2B | 36.0B | 66.2B | 256.6B |
| Operating Income (EBIT) | (14.2B) | (14.0B) | (11.1B) | (52.4B) | 214.7B |
| Non-Operating | |||||
| Interest Income | 6.0B | 6.3B | 8.4B | 8.2B | 4.5B |
| Interest Expense | 2.2B | 2.2B | 1.0B | 67.9M | 94.0M |
| Net Interest Income | 3.8B | 4.0B | 7.3B | 8.1B | 4.4B |
| Other Non-Op Income/Expense | (13.5B) | (7.3B) | (26.5B) | (9.8B) | 22.9B |
| Non-Operating Income (excl Interest) | 11.4B | 5.0B | 18.5B | 9.8B | (23.0B) |
| EBT (Pre-Tax Income) | (27.7B) | (21.3B) | (37.6B) | (62.2B) | 237.6B |
| Income Tax Expense | (1.2B) | 523.6M | (2.0B) | (6.8B) | 54.9B |
| Bottom Line | |||||
| Net Income | (15.6B) | (15.6B) | (30.4B) | (55.4B) | 182.6B |
| Earnings from Cont. Ops | (26.6B) | (21.8B) | (35.6B) | (55.4B) | 182.7B |
| Earnings from Discont. Ops | (57.4M) | 89.8M | 43.6M | — | — |
| Bottom Line Net Income | (15.6B) | (15.6B) | (30.4B) | (55.4B) | 182.6B |
| Per Share | |||||
| Basic EPS | (₩690) | (₩690) | (₩1,296) | (₩2,177) | ₩6,974 |
| Diluted EPS | (₩690) | (₩690) | (₩1,296) | (₩2,177) | ₩6,974 |
| Revenue Per Share | ₩1,403 | ₩1,330 | ₩1,082 | ₩543 | ₩17,996 |
| Shares | |||||
| Basic Shares Outstanding | 22.6M | 22.6M | 23.5M | 25.5M | 26.2M |
| Diluted Shares Outstanding | 22.6M | 22.6M | 23.5M | 25.5M | 26.2M |
| Profitability Metrics | |||||
| EBITDA | (22.5B) | (16.1B) | (10.8B) | (57.5B) | 242.6B |
| D&A | 3.0B | 3.0B | 2.3B | 4.7B | 4.8B |
| EBIT | (25.6B) | (19.1B) | (31.6B) | (62.1B) | 237.7B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026